PARP1 and colonic neoplasm: To examine whether the combination of PARP inhibitor PJ34 with 5-aza-dC enhances cytotoxicity in solid cancer cells, the effect of PJ-34 and 5-aza-dC was analyzed in two different colon cancer cells HCT116 and RKO for 3 days.